356 related articles for article (PubMed ID: 17060864)
1. De novo hepatocellular carcinoma in recurrent liver cirrhosis after liver transplantation for benign hepatic disease: is a deceased donor re-transplantation justified?
Sotiropoulos GC; Frilling A; Molmenti EP; Brokalaki EI; Beckebaum S; Omar OS; Broelsch CE; Malagó M
Transplantation; 2006 Oct; 82(8):1112. PubMed ID: 17060864
[No Abstract] [Full Text] [Related]
2. Cirrhosis of mixed etiology (hepatitis C virus and alcohol): Posttransplantation outcome-Comparison with hepatitis C virus-related cirrhosis and alcoholic-related cirrhosis.
Aguilera V; Berenguer M; Rubín A; San-Juan F; Rayón JM; Prieto M; Mir J
Liver Transpl; 2009 Jan; 15(1):79-87. PubMed ID: 19109849
[TBL] [Abstract][Full Text] [Related]
3. Donor origin de novo HCC in a noncirrhotic liver allograft 3 years after liver transplantation.
Vernadakis S; Poetsch M; Weber F; Treckmann J; Mathe Z; Baba HA; Paul A; Kaiser GM
Transpl Int; 2010 Mar; 23(3):341-3. PubMed ID: 19737373
[No Abstract] [Full Text] [Related]
4. The natural history of hepatitis C cirrhosis after liver transplantation.
Firpi RJ; Clark V; Soldevila-Pico C; Morelli G; Cabrera R; Levy C; Machicao VI; Chaoru C; Nelson DR
Liver Transpl; 2009 Sep; 15(9):1063-71. PubMed ID: 19718647
[TBL] [Abstract][Full Text] [Related]
5. Recurrence of diseases following orthotopic liver transplantation.
Kotlyar DS; Campbell MS; Reddy KR
Am J Gastroenterol; 2006 Jun; 101(6):1370-8. PubMed ID: 16771963
[TBL] [Abstract][Full Text] [Related]
6. Killer cell immunoglobulin-like receptor genotype and killer cell immunoglobulin-like receptor-human leukocyte antigen C ligand compatibility affect the severity of hepatitis C virus recurrence after liver transplantation.
de Arias AE; Haworth SE; Belli LS; Burra P; Pinzello G; Vangeli M; Minola E; Guido M; Boccagni P; De Feo TM; Torelli R; Cardillo M; Scalamogna M; Poli F
Liver Transpl; 2009 Apr; 15(4):390-9. PubMed ID: 19326408
[TBL] [Abstract][Full Text] [Related]
7. De novo hepatocellular carcinoma in a liver allograft associated with recurrent hepatitis B.
Torbenson M; Grover D; Boitnott J; Klein A; Molmenti E
Transplant Proc; 2005 Jun; 37(5):2205-6. PubMed ID: 15964379
[TBL] [Abstract][Full Text] [Related]
8. Impact of donor graft steatosis on overall outcome and viral recurrence after liver transplantation for hepatitis C virus cirrhosis.
Briceño J; Ciria R; Pleguezuelo M; de la Mata M; Muntané J; Naranjo A; Sánchez-Hidalgo J; Marchal T; Rufián S; López-Cillero P
Liver Transpl; 2009 Jan; 15(1):37-48. PubMed ID: 19109846
[TBL] [Abstract][Full Text] [Related]
9. Recurrent nonhepatic and de novo malignancies after liver transplantation.
Jain A; Fiaz O; Sheikh B; Sharma R; Safadjou S; Kashyap R; Bryan L; Batzold P; Orloff M
Transplantation; 2009 Sep; 88(5):706-10. PubMed ID: 19741469
[TBL] [Abstract][Full Text] [Related]
10. Hepatic venous pressure gradient to assess fibrosis and its progression after liver transplantation for HCV cirrhosis.
Samonakis DN; Cholongitas E; Thalheimer U; Kalambokis G; Quaglia A; Triantos CK; Mela M; Manousou P; Senzolo M; Dhillon AP; Patch D; Burroughs AK
Liver Transpl; 2007 Sep; 13(9):1305-11. PubMed ID: 17763383
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis C recurrence and fibrosis progression are not increased after living donor liver transplantation: a single-center study of 289 patients.
Schmeding M; Neumann UP; Puhl G; Bahra M; Neuhaus R; Neuhaus P
Liver Transpl; 2007 May; 13(5):687-92. PubMed ID: 17457911
[TBL] [Abstract][Full Text] [Related]
12. The indications for orthotopic liver transplantation.
MacDougall BR; Williams R
Transplant Proc; 1979 Mar; 11(1):247-51. PubMed ID: 222017
[No Abstract] [Full Text] [Related]
13. Recurrent hepatitis C virus infection after liver transplantation.
Arnold JC; Kraus T; Otto G; Müller HM; Hofmann W; Gmelin K; Goeser T; Kommerell B; Theilmann L
Transplant Proc; 1992 Dec; 24(6):2646-7. PubMed ID: 1334594
[No Abstract] [Full Text] [Related]
14. Cirrhosis after orthotopic liver transplantation in the absence of primary disease recurrence.
Seyam M; Neuberger JM; Gunson BK; Hübscher SG
Liver Transpl; 2007 Jul; 13(7):966-74. PubMed ID: 17370332
[TBL] [Abstract][Full Text] [Related]
15. Liver transplantation for solitary hepatocellular carcinoma less than 3 cm in diameter in Child A cirrhosis.
Poon RT
Dig Dis; 2007; 25(4):334-40. PubMed ID: 17960069
[TBL] [Abstract][Full Text] [Related]
16. Hepatocellular carcinoma developed on compensated cirrhosis: resection as a selection tool for liver transplantation.
Scatton O; Zalinski S; Terris B; Lefevre JH; Casali A; Massault PP; Conti F; Calmus Y; Soubrane O
Liver Transpl; 2008 Jun; 14(6):779-88. PubMed ID: 18508370
[TBL] [Abstract][Full Text] [Related]
17. Survival outcomes in liver transplantation for hepatocellular carcinoma, comparing impact of hepatitis C versus other etiology of cirrhosis.
Bozorgzadeh A; Orloff M; Abt P; Tsoulfas G; Younan D; Kashyap R; Jain A; Mantry P; Maliakkal B; Khorana A; Schwartz S
Liver Transpl; 2007 Jun; 13(6):807-13. PubMed ID: 17539001
[TBL] [Abstract][Full Text] [Related]
18. [Hepatology 2010].
Thimme R; Spangenberg HC; Blum HE
Dtsch Med Wochenschr; 2010 Jun; 135(25-26):1290-4. PubMed ID: 20535665
[No Abstract] [Full Text] [Related]
19. A decade of liver transplantation at Mayo Clinic in Florida.
Nguyen JH; Dickson RC; Harnois DM
Clin Transpl; 2008; ():127-35. PubMed ID: 19708451
[TBL] [Abstract][Full Text] [Related]
20. The evolution of the role of liver transplantation in treating alcoholic cirrhosis in Greece.
Imvrios G; Papanikolaou V; Tsoulfas G; Vasiliadis T; Kardassis D; Papagiannis A; Goulis I; Giakoustidis D; Antoniadis N; Fouzas I; Patsiaoura K; Ntinas A; Ouzounidis N; Vrochides D; Katsika E; Diplaris K; Miserlis G; Takoudas D
Transplant Proc; 2008 Nov; 40(9):3189-90. PubMed ID: 19010229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
